Clinical Trials on Anal, Colon, and Rectal Cancers
Total 0 results
Nothing found
Sponsors and Collaborators
- Health Parametrics Inc.
- Jeffrey W. Clark, MD
- Marilia Medicine School
- MingSight Pharmaceuticals Pty Limited
- John Granton
- European Network For Smoking and Tobacco Prevention
- Kawin Technology Share-holding Co., Ltd.
- Northern California Melanoma Center
- Jeffrey Rudolph
- Mitchell Scheiman
- Zahra Rabbani Khah
- Montreal Neurological Institute and Hospital
- New York State Health Foundation
- Medtronic Atrial Fibrillation Solutions
- Ionis Pharmaceuticals
- The Third Hospital of Changsha
- Honda R and D Americas, Inc.
- Wushan County People's Hospital
- CTC Bio, Inc.
- Rex Bionics Plc
- View Full List
Medical Conditions
- Advanced Esophageal Cancers
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Metastatic Spine Lesions
- Pregnancy-Related Condition, Unspecified
- Renal Cancer Metastatic
- Brain MRI
- Locally Advanced NSCLC
- Liver Hemangioma
- Periferal Arterial Occlusive Disease, PAOD
- Hyperthyroidism, Autoimmune
- LSIL
- Waldenstrom's Macroglobulinemia Recurrent
- Fasting, Diet, Chemotherapy, Toxicity
- ACTH-Secreting Pituitary Adenoma
- Pancreatic Neoplasms
- Ascaris Suum
- H.Pylori Infection
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- HDT-AHCT
- Primary Generalized Dystonia
- View Full List
Drug Interventions
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Postoperative analgesia management
- Fludarabine
- Pentostatin
- Levcromakalim
- Hydroxychloroquine
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- ESK981
- Levobupivacaine, clonidine
- Rifaximin
- 200 µg doxorubicin-containing MNA
- Ombrabulin (AVE8062)
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- AZD7798
- Bendamustine
- CKD-519
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Nimotuzumab
- Toripalimab plus Anlotinib
- View Full List
CROs by country
- Contract Research Organizations in Brazil
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Denmark
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Liberia
- Contract Research Organizations in Morocco
- Contract Research Organizations in Philippines
- Contract Research Organizations in Senegal
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Uruguay
- CRO list by country